Alpha cognition inc. reports first quarter 2025 financial results and operating overview

Vancouver, british columbia--(business wire)--alpha cognition inc. (nasdaq: acog) (“alpha cognition”, or the “company”) today announced its financial results for the first quarter ended march 31, 2025. “we closed the quarter on a strong note, launching zunveyl® to the long-term care market,” said michael mcfadden, chief executive officer. “we feel that the company is operating at a high level and are on schedule and within budget on all of our launch plans. early market feedback on zunveyl util.
ACOG Ratings Summary
ACOG Quant Ranking